Department of Pediatric Urology, Pediatric Surgery & MAS, Ankura Hospitals for Women and Children, Hyderabad, India.
Department of Pediatric Nephrology, Apollo Hospitals, Hyderabad, India.
Urology. 2024 Feb;184:189-194. doi: 10.1016/j.urology.2023.10.011. Epub 2023 Nov 3.
To review our experience with managing poorly functioning kidneys with ureteropelvic junction obstruction (PFK-UPJO) with differential renal function (DRF) <10% by a trial of temporary drainage, as the management of such kidneys is controversial. We also studied the histopathologic changes in the nephrectomy specimens of persistent PFK-UPJO, as tubulointerstitial damage may predispose to hypertension.
A retrospective review of cases undergoing treatment for unilateral UPJO over 5-year period in 2 centers was conducted. In PFK-UPJO, 4-6 weeks trial of drainage with double J stent or percutaneous nephrostomy was employed. Those kidneys that improved DRF to >10% underwent pyeloplasty, while persistent PFK underwent nephrectomy; the specimens were studied for interstitial fibrosis/tubular atrophy (IF/TA), arterial lesions, and arteriole lesions.
Of 402 patients with unilateral UPJO that underwent surgical management, 17 (4.1%) had PFK-UPJO. After 4-6 weeks trial of drainage, 6 kidneys (35.2%) with improved DRF underwent pyeloplasty, while 11 kidneys with persistent PFK underwent nephrectomy; significant IF/TA, arterial, and arteriolar changes were noted in 9 (82%), 9 (82%), and 4 (36%) kidneys, respectively, including 7 kidneys in normotensive children. Two (11.7%) children had hypertension at presentation; 1 child remains hypertensive even after nephrectomy.
In PFK-UPJO, trial of temporary drainage seems appropriate to decide plan of management; 35% of such kidneys improved function after drainage. Most persistent PFK demonstrated severe and irreversible histologic changes that may predispose to hypertension if they are preserved, and we suggest that such kidneys may be removed. Long-term follow-up of all preserved PFK-UPJO is strongly recommended.
回顾我们在处理功能不良肾脏合并肾盂输尿管连接部梗阻(PFK-UPJO)伴分肾功能(DRF)<10%的经验,这些肾脏的处理存在争议。我们还研究了持续性 PFK-UPJO 肾切除标本的组织病理学变化,因为小管间质损伤可能导致高血压。
对 2 个中心 5 年内单侧 UPJO 治疗病例进行回顾性分析。在 PFK-UPJO 中,采用双 J 支架或经皮肾造瘘术进行 4-6 周的引流试验。那些 DRF 改善>10%的肾脏行肾盂成形术,而持续性 PFK 则行肾切除术;研究标本的间质纤维化/肾小管萎缩(IF/TA)、动脉病变和小动脉病变。
在 402 例接受单侧 UPJO 手术治疗的患者中,有 17 例(4.1%)患有 PFK-UPJO。引流试验 4-6 周后,6 例(35.2%)DRF 改善的肾脏行肾盂成形术,而 11 例持续性 PFK 行肾切除术;9 例(82%)、9 例(82%)和 4 例(36%)肾脏分别出现显著的 IF/TA、动脉和小动脉病变,包括 7 例在正常血压儿童中。2 例(11.7%)患儿在就诊时即有高血压;1 例患儿即使在肾切除术后仍有高血压。
在 PFK-UPJO 中,临时引流试验似乎适合决定治疗方案;35%的此类肾脏在引流后功能改善。大多数持续性 PFK 显示出严重和不可逆转的组织学变化,如果保留这些肾脏,可能会导致高血压,我们建议可以将这些肾脏切除。强烈建议对所有保留的 PFK-UPJO 进行长期随访。